Clinical Trial Update: Transplant Antibody-Mediated Rejection: Guiding Effective Treatments [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating treatments for antibody-mediated rejection in kidney transplant patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibody-mediated Rejection
• Kidney Transplant Rejection

Snippet

Sponsor: Imperial College London | Conditions: Kidney Transplant Rejection, Antibody-mediated Rejection | Phase 3 | Status: TERMINATED